Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis

Acta Radiologica - Tập 57 Số 9 - Trang 1149-1155 - 2016
Yuchen Qiu1, Maxine Tan1, Scott McMeekin2, Theresa Thai2, Kai Ding2, Kathleen N. Moore2, Hong Liu1, Bin Zheng1
1School of Electrical and Computer Engineering, University of Oklahoma, Norman, Oklahoma, USA
2Health Science Center of University of Oklahoma, Oklahoma City, Oklahoma, USA

Tóm tắt

Background In current clinical trials of treating ovarian cancer patients, how to accurately predict patients’ response to the chemotherapy at an early stage remains an important and unsolved challenge. Purpose To investigate feasibility of applying a new quantitative image analysis method for predicting early response of ovarian cancer patients to chemotherapy in clinical trials. Material and Methods A dataset of 30 patients was retrospectively selected in this study, among which 12 were responders with 6-month progression-free survival (PFS) and 18 were non-responders. A computer-aided detection scheme was developed to segment tumors depicted on two sets of CT images acquired pre-treatment and 4–6 weeks post treatment. The scheme computed changes of three image features related to the tumor volume, density, and density variance. We analyzed performance of using each image feature and applying a decision tree to predict patients’ 6-month PFS. The prediction accuracy of using quantitative image features was also compared with the clinical record based on the Response Evaluation Criteria in Solid Tumors (RECIST) guideline. Results The areas under receiver operating characteristic curve (AUC) were 0.773 ± 0.086, 0.680 ± 0.109, and 0.668 ± 0.101, when using each of three features, respectively. AUC value increased to 0.831 ± 0.078 when combining these features together. The decision-tree classifier achieved a higher predicting accuracy (76.7%) than using RECIST guideline (60.0%). Conclusion This study demonstrated the potential of using a quantitative image feature analysis method to improve accuracy of predicting early response of ovarian cancer patients to the chemotherapy in clinical trials.

Từ khóa


Tài liệu tham khảo

10.3322/caac.21254

10.1038/nrc2291

10.1016/j.soncn.2010.11.005

10.1093/annonc/mdr489

10.1148/radiology.215.3.r00jn25761

10.1016/j.ejrad.2008.02.019

10.1038/sj.onc.1210302

10.1038/nature11453

10.1186/1757-2215-2-13

10.1016/0090-8258(90)90076-W

10.1016/S0140-6736(10)61268-8

10.1038/nrclinonc.2010.47

10.1016/j.ejca.2008.10.026

Andreopoulou E, 2002, Anticancer Res, 22, 1903

10.1158/0008-5472.CAN-12-0058

10.1038/nrclinonc.2011.156

10.1016/S1076-6332(05)80696-8

10.1088/0031-9155/59/11/2767

10.1016/S1076-6332(03)80557-3

10.1007/s10439-010-0210-4

10.1016/j.jbi.2007.06.008

10.1158/1078-0432.CCR-09-1624

10.1093/jnci/djq310

10.1200/JCO.2007.11.5345

10.1002/hep.24108

10.1016/j.ygyno.2014.01.031

Thông tin
Thông tin xuất bản

Acta Radiologica

Tập 57 Số 9

1149-1155

Thông tin tác giả